Merger Monday returns ...

It's been a while since several deals have been simultaneously announced at the beginning of the week but there is a possibility of it happening today.

That's because overnight the likes of the Wall Street Journal, the Financial Times and Bloomberg were all reporting US-listed biopharmaceutical company Amgen is close to buying Horizon Therapeutics for around $116.5 a share or around $26 billion. Below are the relevant links:..